Magnetic resonance imaging also revealed heterogenous pituitary gland, thickened stalk, and loss of a hot signal (T1 weighted) of the posterior pituitary, which was suggestive of Langerhans cell
Erdheim-Chester disease: evidence for a disease entity different from Langerhans cell
To the Editor: Langerhans cell
histiocytosis (LCH) is a rare disease that usually occurs in the first two decades of life. Multisystem-LCH (MS-LCH) mainly affects youth.
sarcoma (LCS) is a rare neoplasm of Langerhans cells
that usually arises de novo, although it can progress from either Langerhans cell
histiocytosis or a low-grade B-cell lymphoma.
The histological appearance typically seen in ECD is CD68(+), CD1a(-), S-100(-/low) non langerhans cell
histiocytosis (LCH) is an uncommon disease of unknown pathogenesis.
Three patients had lesions that involved the skull only [Langerhans cell histiocytosis (LCH): 2, fibrous dysplasia: 1], 3 had lesions that partly infiltrated the dura (Langerhans cell
histiocytosis: 2, follicular carcinoma metastasis: 1); brain involvement was not seen (Table 3).
histiocytosis (LCH) is a neoplastic proliferation of Langerhans cells
histiocytosis (LCH) is a rare proliferative disorder with unknown etiologies.
histiocytosis (LCH) results from an abnormal accumulation of immature Langerhans cells
, causing tumor formation or organ damage.
histiocytosis (LCH) is a rare disease characterized by granulomatous lesions consisting of clonal CD1a+/CD207+/S100+ immature dendritic cells and various inflammatory cells.
Histiocytosis (LCH) is an uncommon multisystem disorder of unknown etiology, characterized by accumulation of histiocytes in various tissues.